augment
-
Biologics
Wright Medical Group N.V. Announces Update to Medicare Transitional Device Pass-Through Payment for AUGMENT® Regenerative Solutions
AMSTERDAM, The Netherlands, July 20, 2020 (GLOBE NEWSWIRE) — Wright Medical Group N.V. (NASDAQ: WMGI) today announced that the Centers…
Read More » -
Biologics
Wright Medical Group N.V. Highlights Recent Innovations and Clinical Data at the American Orthopaedic Foot & Ankle Society (AOFAS) 2019 Annual Meeting
AMSTERDAM, The Netherlands, Sept. 12, 2019 (GLOBE NEWSWIRE) — Wright Medical Group N.V. (NASDAQ: WMGI) announced it will highlight new…
Read More » -
Biologics
MCRA Assists Wright Medical Group, Inc. with Obtaining FDA PMA Approvable Decision for Augment® Bone Graft
WASHINGTON, DC, Nov. 6, 2014 – Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) announced today its role in the successful approvable…
Read More » -
BioMimetic Therapeutics Ships Augment™ Bone Graft to Canadian Distributor; Product Now Available for Sale to Canadian Customers
Franklin, Tenn. – December 11, 2009 – BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that the Company has shipped its…
Read More »